Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92


The potential for bio-mediators and biomarkers in pediatric traumatic brain injury and neurocritical care.

Kochanek PM, Berger RP, Fink EL, Au AK, Bayır H, Bell MJ, Dixon CE, Clark RS.

Front Neurol. 2013 Apr 26;4:40. doi: 10.3389/fneur.2013.00040.


Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification.

Wolahan SM, Hirt D, Glenn TC.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25.


Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.

Huang XJ, Glushakova O, Mondello S, Van K, Hayes RL, Lyeth BG.

J Neurotrauma. 2015 Aug 15;32(16):1179-89. doi: 10.1089/neu.2015.3873.


Utility Of Serum Biomarkers In The Diagnosis and Stratification Of Mild Traumatic Brain Injury.

Lewis LM, Schloemann D, Papa L, Fucetola R, Bazarian J, Lindburg M, Welch R.

Acad Emerg Med. 2017 Feb 7. doi: 10.1111/acem.13174. [Epub ahead of print]


In Children and Youth with Mild and Moderate Traumatic Brain Injury, Glial Fibrillary Acidic Protein Out-Performs S100β in Detecting Traumatic Intracranial Lesions on Computed Tomography.

Papa L, Mittal MK, Ramirez J, Ramia M, Kirby S, Silvestri S, Giordano P, Weber K, Braga CF, Tan CN, Ameli NJ, Lopez M, Zonfrillo M.

J Neurotrauma. 2016 Jan 1;33(1):58-64. doi: 10.1089/neu.2015.3869.


Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.

Mondello S, Linnet A, Buki A, Robicsek S, Gabrielli A, Tepas J, Papa L, Brophy GM, Tortella F, Hayes RL, Wang KK.

Neurosurgery. 2012 Mar;70(3):666-75. doi: 10.1227/NEU.0b013e318236a809.


Quo vadis 2010? - carpe diem: challenges and opportunities in pediatric traumatic brain injury.

Kochanek PM, Bell MJ, Bayır H.

Dev Neurosci. 2010;32(5-6):335-42. doi: 10.1159/000323016. Review.


Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum.

Fraser DD, Close TE, Rose KL, Ward R, Mehl M, Farrell C, Lacroix J, Creery D, Kesselman M, Stanimirovic D, Hutchison JS; Canadian Critical Care Translational Biology Group..

Pediatr Crit Care Med. 2011 May;12(3):319-24. doi: 10.1097/PCC.0b013e3181e8b32d.


Clinical applications of biomarkers in pediatric traumatic brain injury.

Sandler SJ, Figaji AA, Adelson PD.

Childs Nerv Syst. 2010 Feb;26(2):205-13. doi: 10.1007/s00381-009-1009-1. Review.


Biomarkers in the clinical diagnosis and management of traumatic brain injury.

Hergenroeder GW, Redell JB, Moore AN, Dash PK.

Mol Diagn Ther. 2008;12(6):345-58. doi: 10.2165/1250444-200812060-00002.


Brain injury biomarkers as outcome predictors in pediatric severe traumatic brain injury.

Daoud H, Alharfi I, Alhelali I, Charyk Stewart T, Qasem H, Fraser DD.

Neurocrit Care. 2014 Jun;20(3):427-35. doi: 10.1007/s12028-013-9879-1. Review.


Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury.

Shore PM, Berger RP, Varma S, Janesko KL, Wisniewski SR, Clark RS, Adelson PD, Thomas NJ, Lai YC, Bayir H, Kochanek PM.

J Neurotrauma. 2007 Jan;24(1):75-86.


Insight into Pre-Clinical Models of Traumatic Brain Injury Using Circulating Brain Damage Biomarkers: Operation Brain Trauma Therapy.

Mondello S, Shear DA, Bramlett HM, Dixon CE, Schmid KE, Dietrich WD, Wang KK, Hayes RL, Glushakova O, Catania M, Richieri SP, Povlishock JT, Tortella FC, Kochanek PM.

J Neurotrauma. 2016 Mar 15;33(6):595-605. doi: 10.1089/neu.2015.4132.


Translating biomarkers from research to clinical use in pediatric neurocritical care: focus on traumatic brain injury and cardiac arrest.

Prout AJ, Wolf MS, Fink EL.

Curr Opin Pediatr. 2017 Mar 17. doi: 10.1097/MOP.0000000000000488. [Epub ahead of print]


Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.

Diaz-Arrastia R, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, McMahon PJ, Inoue T, Yuh EL, Lingsma HF, Maas AI, Valadka AB, Okonkwo DO, Manley GT; TRACK-TBI Investigators..

J Neurotrauma. 2014 Jan 1;31(1):19-25. doi: 10.1089/neu.2013.3040.


Cerebrospinal Fluid Markers of Macrophage and Lymphocyte Activation After Traumatic Brain Injury in Children.

Newell E, Shellington DK, Simon DW, Bell MJ, Kochanek PM, Feldman K, Bayir H, Aneja RK, Carcillo JA, Clark RS.

Pediatr Crit Care Med. 2015 Jul;16(6):549-57. doi: 10.1097/PCC.0000000000000400.


Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury.

Papa L, Brophy GM, Welch RD, Lewis LM, Braga CF, Tan CN, Ameli NJ, Lopez MA, Haeussler CA, Mendez Giordano DI, Silvestri S, Giordano P, Weber KD, Hill-Pryor C, Hack DC.

JAMA Neurol. 2016 May 1;73(5):551-60. doi: 10.1001/jamaneurol.2016.0039.


Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI.

Berger RP, Hayes RL, Richichi R, Beers SR, Wang KK.

J Neurotrauma. 2012 Jan 1;29(1):162-7. doi: 10.1089/neu.2011.1989.


Risk Adjustment In Neurocritical care (RAIN)--prospective validation of risk prediction models for adult patients with acute traumatic brain injury to use to evaluate the optimum location and comparative costs of neurocritical care: a cohort study.

Harrison DA, Prabhu G, Grieve R, Harvey SE, Sadique MZ, Gomes M, Griggs KA, Walmsley E, Smith M, Yeoman P, Lecky FE, Hutchinson PJ, Menon DK, Rowan KM.

Health Technol Assess. 2013 Jun;17(23):vii-viii, 1-350. doi: 10.3310/hta17230.


Increased CSF concentrations of myelin basic protein after TBI in infants and children: absence of significant effect of therapeutic hypothermia.

Su E, Bell MJ, Kochanek PM, Wisniewski SR, Bayir H, Clark RS, Adelson PD, Tyler-Kabara EC, Janesko-Feldman KL, Berger RP.

Neurocrit Care. 2012 Dec;17(3):401-7. doi: 10.1007/s12028-012-9767-0.

Supplemental Content

Support Center